This is a discussion on TA140: Ulcerative colitis (subacute manifestations) - infliximab within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Ulcerative colitis (subacute manifestations) - infliximab . It links to the published guidance and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The summary for the published technology appraisal on Ulcerative colitis (subacute manifestations) - infliximab . It links to the published guidance and key documents.
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA163: Ulcerative colitis (acute exacerbations) - infliximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| Remicade for ulcerative colitis - policy criteria | chantell.reagan | Managed Care Issues for Injectable Drugs | 0 | 02-12-2009 12:46 PM |
| TA163: Ulcerative colitis (acute exacerbations) - infliximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 12-16-2008 09:44 PM |
| Statins May Be Useful for Systemic Sclerosis Manifestations | industry_news | Other Clinical Pharmacy News | 0 | 09-23-2008 02:30 PM |
| Thalidomide Helpful in Hard-To-Treat HIV Colitis | industry_news | Other Clinical Pharmacy News | 0 | 08-05-2008 10:20 AM |